DAPAgliflozin for Renal Protection in Heart Transplant Recipients
Clinical trial NCT05321706 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05321706
- Sponsor
- Oslo University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-08
- Primary completion
- 2028-09-30
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.